Senior Product Manager, Oncology
BillionToOne
Summary
We are looking for a Senior Product Manager, Oncology to lead and manage our therapy selection product family, Northstar Select. This role will be working closely with R&D, clinical, engineering, sales, marketing, and company leadership to lead new assay development as well as existing assay enhancements. The ideal candidate has experience launching molecular diagnostic testing assays (including FDA-approved assays), is obsessed with delivering a delightful customer experience, and thrives in a fast-paced entrepreneurial environment. This role is a hybrid (onsite 3 days/week) position and reports directly to the Head of Product, Oncology.
Job description
Responsibilities
- Understand the market and design a winning product concept: As the product owner, be the Number 1 expert within the company about user needs and desires, the market, and how our technology assets can solve their problems.
- Plan and execute product launch: Understand and plan for every element that touches the product launch, including the core clinical assay, the user-facing software apps, the internal workflow, regulatory and legal constraints, and requirements, and support teams focused on marketing and PR activities.
- End-to-end user experience: Design and deliver the most seamless and delightful user experience for the entire process, together with a UX designer and other stakeholders.
- Program management: Get the product to the finish line by mobilizing relevant internal and external resources, driving timelines, getting stakeholders to agree on a solution, sourcing external vendors, etc.
- Continuous iterations and improvements: Monitor the users' voice and behaviors, the key metrics, and key market trends for the product-line and identify areas of improvement.
Qualifications
- 5-10 years of experience in product management
- Experience driving product vision, go-to-market strategy, and product requirements
- Experience with launching a product from start to finish
- Experience working with diverse teams to gather requirements and rally them to get a complex product launched
- Experience with IVD product management
- Experience with launching and managing NGS-based diagnostic testing assays is a strong plus
- Experience with launching and managing clinical genetic testing products is a huge plus
Nice-To-Haves
- Oncology experience a plus
- Another advanced degree (Masters/PhD) in molecular biology, bioengineering, medicine, chemical biology, or a related field is strongly preferred
Requirements
- 5-10 years of experience in product management
- Experience driving product vision, go-to-market strategy, and product requirements
- Experience with launching a product from start to finish
- Experience working with diverse teams to gather requirements and rally them to get a complex product launched
- Experience with IVD product management
- Experience with launching and managing NGS-based diagnostic testing assays is a strong plus
- Experience with launching and managing clinical genetic testing products is a huge plus
- Oncology experience a plus
- Advanced degree (Masters/PhD) in molecular biology, bioengineering, medicine, chemical biology, or a related field is strongly preferred
Benefits
- Medical, Dental & Vision
- 401(k) Matching
- Paid Parental Leave
- Equity Options
- Corporate Bonus Program
- Free Daily On-Site Lunches
- On-Site Gym
- Free On-Site EV Charging
- Fertility Benefits
- Unlimited PTO
Company overview
BillionToOne is a precision diagnostics company headquartered in Menlo Park, California, founded in 2016 with a mission to make molecular diagnostics more accurate, efficient, and accessible. The company has developed a proprietary Quantitative Counting Templates (QCT) molecular counting platform that can accurately count DNA molecules at the single-molecule level, enabling unprecedented sensitivity in disease detection. BillionToOne operates as a publicly traded company on NASDAQ under the symbol BLLN, having completed a successful IPO in 2025. The company's diagnostic platforms include UNITY Complete for non-invasive prenatal testing, which assesses fetal risk for recessive conditions and aneuploidies from a single maternal blood sample, and Northstar oncology products for cancer therapy selection and treatment response monitoring. With over 500 employees and multiple CLIA/CAP accredited laboratories, BillionToOne represents a significant advancement in quantitative molecular diagnostics, combining breakthrough science with scalable commercial operations to transform healthcare delivery.